AbA is a selective inhibitor of androgen biosynthesis through the potential and irreversible blockade of cytochrome P450 family 17 subfamily A member 1 (CYP17A1), resulting in the absence of androgens in the blood and within tumour cells [8,9]. Here, CYP17A1 is linked to neoplasm.